First call from JPIAMR
InnovaResistance, published in January 2014, is the first joint transnational call of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), which is promoted by 14 funding agencies from 12 countries with a total budget of 13,8M€.
The primary aim of InnovaResistance is to combine the resources, infrastructures, and research strengths of multiple countries in order to overcome antibiotic resistance. The goal is to foster multinational translational research collaborations that can accomplish more than individual countries working independently, leading to improved control of bacterial infections.
- We are especially pleased that our first call includes Canada, as this highlights that addressing antimicrobial resistance is a global challenge. To make a difference we need to look beyond Europe, says Mats Ulfendahl, Chair of the JPIAMR management board and representative from the Swedish Research Council.
- Antimicrobial resistance is one of the top public health problems and requires immediate international action. We are thrilled to start this partnership that will synergize the research efforts of Europeans and Canadians for the development of novel antibiotics, and develop strategies that will protect our population from infectious threats, says Dr. Marc Ouellette, Scientific Director of the CIHR Institute of Infection and Immunity. The call is a two-step process and by the deadline March 15th, 2014, 94 pre-proposals were submitted. The result of the consensus meeting is that 41 pre-proposals have been invited to submit full proposals with a total requested funding of EUR 47.5M€.
The final results will be published by November/December 2014.